sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú

While the first autologous cell therapy commercial products have shown tremendous clinical success, scaling out these therapies while considering individual patient processes is a new challenge.

This ebook discusses efficiencies specific to early biopharmaceutical formulation development and biomanufacturing continuous processing.

How can a patient-centric outlook help scientists tackle the key challenges of early drug development.

Utilize an all-encompassing approach to enable an effective dosage form faster to market.

Summary: Three early drug development experts present insights and techniques to help your clients get their molecules from preclinical to Phase 1 studies.